Condition
Mesothelioma, Malignant clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Mesothelioma, Malignant clinical trials that are recruiting, at sites in 9 countries (most in United States (7), United Kingdom (2), China (1)). By phase: Phase 1/2 (3), Phase 1 (2), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 9Countries
Newest Mesothelioma, Malignant clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Partial pleurectomy to relieve symptoms from unresectable pleural mesothelioma. | — | Chicago, Illinois | Recruiting | Aug 17, 2025 |
| Local anesthesia thoracoscopy for diagnosing pleural effusion | — | Athens, Attica | Recruiting | Apr 27, 2025 |
| SW-682 for advanced solid tumors | Phase 1 | Scottsdale, Arizona and 7 other locations | Recruiting | Feb 9, 2024 |
| Additional chemotherapy after surgery for malignant peritoneal mesothelioma | Phase 2 | Chicago, Illinois and 12 other locations | Recruiting | Sep 28, 2023 |
| Evaluating a new CAR T-cell therapy for solid tumors expressing MSLN | Phase 1/2 | Gilbert, Arizona and 11 other locations | Recruiting | Sep 25, 2023 |
| Evaluating HTL0039732 for Advanced Solid Tumours | Phase 1/2 | Cambridge and 5 other locations | Recruiting | Jul 13, 2023 |
| Treatment for advanced cancers expressing mesothelin | Phase 1 | Tampa, Florida and 4 other locations | Recruiting | Oct 6, 2022 |
| Combining Sintilimab, Anlotinib, and Chemotherapy for Advanced Pleural Mesothelioma | Phase 2 | Taiyuan, Shanxi and 1 other locations | Recruiting | Jan 12, 2022 |
| Analyzing solid tumors for HLA loss and collecting T cells for CAR T-cell therapy | — | Gilbert, Arizona and 15 other locations | Recruiting | Jul 28, 2021 |
| Tulmimetostat treatment for advanced solid tumors and lymphomas | Phase 1/2 | Tampa, Florida and 79 other locations | Recruiting | Sep 26, 2019 |
All recruiting trials (10)
-
Partial pleurectomy to relieve symptoms from unresectable pleural mesothelioma.
The team will try a limited partial pleurectomy and decortication to reduce chest symptoms and improve quality of life for people with epithelioid pleural mesothelioma that cannot be completely removed.
-
Local anesthesia thoracoscopy for diagnosing pleural effusion
This study tests if using local anesthesia during a thoracoscopy can help diagnose suspected cancer-related fluid buildup in the chest faster and more comfortably than standard tests.
-
SW-682 for advanced solid tumors
This study is testing a new oral treatment called SW-682 to see if it can help adults with advanced solid tumors that haven't improved with other therapies.
-
Additional chemotherapy after surgery for malignant peritoneal mesothelioma
This study is testing whether giving chemotherapy directly into the abdomen or through an IV after surgery helps people with malignant peritoneal mesothelioma do better.
-
Evaluating a new CAR T-cell therapy for solid tumors expressing MSLN
This study is testing a new CAR T-cell therapy to see if it can safely treat adults with solid tumors like colorectal and lung cancer that express a specific protein.
-
Evaluating HTL0039732 for Advanced Solid Tumours
This study is testing a new drug called HTL0039732, alone and with another treatment, to see if it can help people with advanced solid tumors by boosting their immune response against cancer.
-
Treatment for advanced cancers expressing mesothelin
This study is testing a new treatment called SynKIR-110 to see if it is safe and works for people with advanced cancers that have a specific protein called mesothelin, like ovarian cancer and mesothelioma.
-
Combining Sintilimab, Anlotinib, and Chemotherapy for Advanced Pleural Mesothelioma
This study is testing a new combination of Sintilimab, Anlotinib, and chemotherapy to see if it helps people with advanced pleural mesothelioma who haven't had treatment before.
-
Analyzing solid tumors for HLA loss and collecting T cells for CAR T-cell therapy
This study is testing how often solid tumors lose a key protein that helps the immune system recognize them, while also collecting T cells from patients with high-risk cancers to prepare for future CAR T-cell therapy.
-
Tulmimetostat treatment for advanced solid tumors and lymphomas
This study is testing a new treatment called Tulmimetostat to see if it can help people with advanced solid tumors and lymphomas feel better and fight their cancer.
Related topics
Quick answers
How many Mesothelioma, Malignant clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (7 trials), United Kingdom (2 trials), China (1 trial), Greece (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 1: 2, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.